Global Tissue Banking Market Forecast up to 2024
- January, 2019
- Domain: Healthcare - Biotechnology
Pages:
79
Tables:
25
Charts:
29
Regions/Countries:
4 / 8
Companies:
11
Enquiry Hours:
10
- Get Free 10% Customization in this Report
The conservation and banking of tissues subsequent to donor harvest is an extended medicinal area that has until lately witnessed progress. Nevertheless, in a similar way we bank stem cells, embryos and other tissues at present are likely to govern the biological time for complete tissues through approaches identical to vitrification and controlled hypothermia. A constant growth of tissues and organs scarcity has led to early deaths with consequences in enormous outlays to society. The capacity to bank tissues has an instantaneous effect on transplant medicine, surgical treatment of cancer, combat trauma, and industrial accidents.
Market Analysis - The “Global Tissue Banking Market” is estimated to witness a CAGR of 11.2% during the forecast period 2018–2024. The market is analyzed based on four segments – type, application, tissue type, and regions.
Regional Analysis - The regions covered in the report are North America, Europe, Asia Pacific, and Rest of the World (ROW). North America accounts for the largest share of the tissue banking market, followed by Europe, Asia Pacific, and Rest of the World. More than 44.0% of the market is occupied by North America, with the US being the major contributor to the market growth.
Type Analysis - Based on types, the market is segmented into equipment and consumables. Equipment holds a dominant share in the market and is also the fastest growing segment.
Application Analysis - Based on application areas, the market is segmented into clinical application and research & development. The market is dominated by research & development.
Tissue Type Analysis - Based on tissue banking areas, the market is segmented into cardiovascular tissue, lung tissue, kidney tissue, corneal tissue, and other tissues. The corneal tissue segment is dominant among others in the market.
Key Players - The major players in the market are Thermo Fisher Scientific, Danaher Corporation, Custom Biogenic Solution, Tecan Group, and Brooks Automation, Inc.
Competitive Analysis - The tissue banking market is facing intense competition due to the presence of many players in the market. However, the majority of the market share is occupied by Thermo Fisher Scientific, Danaher Corporation, Custom Biogenic Solution, Tecan Group, and Brooks Automation, Inc. To maintain their leadership, the major players are collaborating with small players who have advanced technology. For instance, in March 2014, Brooks Automation collaborated with BioCision for the development of automated temperature-controlled technology for biobanking and sample handling. This association helped in filling the gap amongst sample handling and automation process.
Benefits - The report provides complete details about the usage and adoption rate of tissue banking in various regions. With that, key stakeholders can know about the major trends, drivers, investments, and vertical player’s initiatives. Moreover, the report provides details about the major challenges that are going to impact on the market growth. Additionally, the report gives the complete details about the key business opportunities to key stakeholders to expand their business and capture the revenue in specific verticals to analyze before investing or expanding the business in this market.
Key Stakeholders 
1 Industry Outlook
1.1 Industry Overview
1.2 Total Addressable Market (TAM)
1.3 Trends of the Market
2 Report Outline
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions
3 Market Snapshot
3.1 Market Definition – Infoholic Research
3.2 Segmented Addressable Market (SAM)
3.3 Industry Trends
3.4 Related Markets
3.4.1 Wound Biologics
3.4.1.1 Trends in Wound Biologics Market
3.4.2 Stem Cell Banking
3.4.2.1 Trends in Stem Cell Banking Market
4 Market Outlook
4.1 Evolution
4.2 Market Segmentation
4.3 Porter 5 (Five) Forces
5 Market Characteristics
5.1 Market Dynamics
5.1.1 Drivers
5.1.1.1 Increasing demand for regenerative medicine
5.1.1.2 Advancements in Tissue Banking Technologies
5.1.2 Restraints
5.1.2.1 Stringent regulatory requirement
5.1.2.2 Ethical Issues
5.1.3 Opportunities
5.1.3.1 Market opportunities in Asia Pacific
5.1.3.2 Mergers and acquisitions
5.1.4 DRO – Impact Analysis
6 Types: Market Size and Analysis
6.1 Overview
6.2 Tissue Banking Equipment
6.3 Accessories and Consumables
7 Application: Market Size and Analysis
7.1 Overview
7.2 Clinical Application
7.3 Research and Development
8 Types: Market Size and Analysis
8.1 Overview
8.2 Cardiovascular Tissue
8.3 Corneal Tissue
8.4 Lungs Tissue
8.5 Kidney Tissue
8.6 Others Tissue
9 Regions: Market Size and Analysis
9.1 Overview
9.2 North America
9.2.1 Overview
9.2.2 US 39
9.2.3 Canada
9.3 Europe
9.3.1 Overview
9.3.2 UK 41
9.3.3 Germany
9.4 Asia Pacific
9.4.1 Overview
9.4.2 India
9.4.3 China
9.4.4 Japan
9.5 Rest of the World
9.5.1 Overview
9.5.2 Brazil
10 Competitive Landscape
11 Vendors Profile
11.1 Thermo Fisher Scientific, Inc.
11.1.1 Overview
11.1.2 Business Units
11.1.3 Geographic Presence
11.1.4 Business focus
11.1.5 SWOT analysis
11.1.6 Business Strategy
11.2 Danaher Corporation
11.2.1 Overview
11.2.2 Business Units
11.2.3 Geographic Revenue
11.2.4 Business Focus
11.2.5 SWOT Analysis
11.2.6 Business Strategies
11.3 Custom Biogenic Systems Inc
11.3.1 Overview
11.3.2 Business Focus
11.3.3 SWOT Analysis
11.3.4 Business Strategies
11.4 Brooks Automation, Inc.
11.4.1 Overview
11.4.2 Business Units
11.4.3 Geographic Presence
11.4.4 Business Focus
11.4.5 SWOT Analysis
11.4.6 Business Strategies
11.5 Tecan Group
11.5.1 Overview
11.5.2 Business Units
11.5.3 Geographic Presence
11.5.4 Business Focus
11.5.5 SWOT Analysis
11.5.6 Business Strategies
12 Companies to Watch for
12.1 Biolife Solutions
12.1.1 Overview
12.2 VWR Corporation
12.2.1 Overview
12.3 PHC Holdings Corporation
12.3.1 Overview
12.3.2 Key Highlights
12.4 Bluechiip Limited
12.4.1 Overview
12.5 Merck KGaA
12.5.1 Overview
12.6 Eppendorf AG
12.6.1 Overview
Annexure
Ø Acronyms
TABLE 1 TISSUE BANKING MARKET REVENUE, BY TYPE, 2017–2024 ($MILLION) 28
TABLE 2 TEMPERATURE RANGE FOR STORAGE OF TISSUES 29
TABLE 3 CURRENT STORAGE METHODS 31
TABLE 4 THERMO FISHER SCIENTIFIC INC.: PRODUCT OFFERINGS 48
TABLE 5 THERMO FISHER SCIENTIFIC: RECENT DEVELOPMENTS 49
TABLE 6 DANAHER CORPORATION: OFFERINGS 55
TABLE 7 DANAHER CORPORATION: RECENT DEVELOPMENTS 56
TABLE 8 CUSTOM BIOGENIC SYSTEMS INC: PRODUCT OFFERINGS 60
TABLE 9 CUSTOM BIOGENIC SYSTEMS INC: RECENT DEVELOPMENTS 61
TABLE 10 BROOKS AUTOMATION, INC.: OFFERINGS 62
TABLE 11 BROOKS AUTOMATION, INC.: RECENT DEVELOPMENTS 63
TABLE 12 TECAN GROUP: OFFERINGS 66
TABLE 13 TECAN GROUP: RECENT DEVELOPMENTS 66
TABLE 14 BIOLIFE SOLUTIONS.: OVERVIEW 71
TABLE 15 BIOLIFE SOLUTIONS.: RECENT DEVELOPMENTS 71
TABLE 16 VWR CORPORATION.: OVERVIEW 72
TABLE 17 VWR CORPORATION.: RECENT DEVELOPMENTS 72
TABLE 18 PHC HOLDINGS CORPORATION.: OVERVIEW 73
TABLE 19 PHC HOLDINGS CORPORATION.: RECENT DEVELOPMENTS 73
TABLE 20 BLUECHIIP LIMITED.: OVERVIEW 74
TABLE 21 BLUECHIIP LIMITED.: RECENT DEVELOPMENTS 74
TABLE 22 MERCK KGAA.: SNAPSHOT 75
TABLE 23 MERCK KGAA.: RECENT DEVELOPMENTS 75
TABLE 24 EPPENDORF AG: OVERVIEW 76
TABLE 25 EPPENDORF AG.: RECENT DEVELOPMENTS 76
Research Framework
Infoholic Research works on a holistic 360° approach in order to deliver high quality, validated and reliable information in our market reports. The Market estimation and forecasting involves following steps:
- Data Collation (Primary & Secondary)
- In-house Estimation (Based on proprietary data bases and Models)
- Market Triangulation
- Forecasting
Market related information is congregated from both primary and secondary sources.
Primary sources
Involved participants from all global stakeholders such as Solution providers, service providers, Industry associations, thought leaders etc. across levels such as CXOs, VPs and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services.
Secondary sources
Include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications along with paid sources such as Factiva, OneSource, Bloomberg among others.
